Tech Company Financing Transactions
Nine Square Therapeutics Funding Round
Nine Square Therapeutics closed a $50 million Series A venture capital round on 7/6/2020. Backers included Apple Tree Partners.
Transaction Overview
Company Name
Announced On
7/6/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
The new company will discover new small-molecule therapeutics for degenerative movement disorders.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
230 Park Ave. 2800
New York, NY 10169
USA
New York, NY 10169
USA
Phone
Email Address
Not Recorded
Overview
The new company will discover new small-molecule therapeutics for degenerative movement disorders including Parkinson's disease and amyotrophic lateral sclerosis (ALS), as well as non-degenerative disorders such as essential tremor and dyskinesias, by integrating computational chemistry, biophysics and computational biology into machine-learning-enabled cell profiling platforms for target identification, chemical optimization and patient stratification.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Spiros Liras
Browse more venture capital transactions:
Prev: 7/6/2020: KlariVis venture capital transaction
Next: 7/6/2020: Codoxo venture capital transaction
Share this article
News on VC Transactions
We document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs